Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Stripping Missouri’s supplier diversity goals stifles state’s prosperity potential, says women’s business advocate
Ending nearly a decade of benchmarks that helped ensure greater equity in state contracts for businesses owned by minorities and women is a move in the wrong direction for Missouri, said Jennifer Brungardt, emphasizing the coming impact of lost opportunities for underrepresented entrepreneurs. “Diversity and economic growth will be stifled without proper support from our…
Capital connector’s message to women: Your investor pool isn’t just sharks; dive in and learn to swim
When it comes to navigating the waters of capital and equity, Women’s Capital Connection angel investment network and the Women’s Business Center serve as a guide to both entrepreneurs and investors, Kelly Sievers shared. “All the education that we do and all the connections that we make, I would say that’s really the key,” explained…
Entrepreneur behind Soul of Santa aims to create Rockefeller Plaza holiday experience on KC’s east side
Tucker Lott hopes an outdoor ice skating rink at 2000 Vine — the home of Vine Street Brewing — will help solidify a new holiday tradition in the 18th and Vine entertainment district, the veteran entrepreneur said. “We wanted to create a holiday atmosphere where families could gather and have fun,” said Lott. “The entire…
Proptech startup Particle Space acquired by LA real estate marketing software firm
The acquisition of a Kansas City proptech startup by one of its first — and biggest — customers offers founder David Biga the opportunity to pivot back to his entrepreneurial roadmap, he said, reflecting on next steps once Particle Space’s technology is fully integrated into its new home. “Build, give back, build, give back,” Biga…